within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01D_VasodilatorsUsedInCardiacDiseases.C01DX13_Efloxate;
model Efloxate 
   extends Pharmacolibrary.Drugs.ATC.C.C01DX13;

  annotation(Documentation(
    info ="<html><body><p>Efloxate is a vasoactive drug classified as a peripheral vasodilator, historically used in the treatment of peripheral vascular disorders such as Raynaud's phenomenon and vascular insufficiency. It is no longer widely used or approved in most countries today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic (PK) studies or peer-reviewed reports with specific PK parameters for efloxate in humans were identified.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Efloxate;
